Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Plus Tegafur/Uracil in Advanced HCC
NCT00464919Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib, tegafur + uracil in hepatocellular carcinoma (HCC), sponsored by National Taiwan University Hospital. Started Apr 2007; status: completed.
02
Drugs
sorafenibtegafur + uracil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00464919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464919.